SA
JAZZ icon

Sanctuary Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sanctuary Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$382K Buy
2,021
+204
+11% +$35.7K ﹤0.01% 1943
2025
Q4 		$309K Sell
1,817
-36
-2% -$5.52K ﹤0.01% 1992
2025
Q3 		$244K Sell
1,853
-487
-21% -$58.4K ﹤0.01% 2132
2025
Q2 		$248K Sell
2,340
-11,735
-83% -$1.27M ﹤0.01% 2028
2025
Q1 		$1.75M Buy
14,075
+882
+7% +$115K 0.01% 836
2024
Q4 		$1.65M Buy
13,193
+1,439
+12% +$170K 0.01% 973
2024
Q3 		$1.49M Buy
11,754
+9,804
+503% +$1.07M 0.01% 1046
2024
Q2 		$213K Buy
+1,950
New +$214K ﹤0.01% 2148

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Sanctuary Advisors's JAZZ Position: Q1 2026 in Review

Sanctuary Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, buying an estimated $35.7K and bringing the position to 2,021 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

Sanctuary Advisors first reported a position in JAZZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.75M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Sanctuary Advisors held 2,021 shares of Jazz Pharmaceuticals worth $382K as of Q1 2026.
  • Sanctuary Advisors bought 204 Jazz Pharmaceuticals shares in Q1 2026, an estimated $35.7K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #1943 holding.
  • Sanctuary Advisors first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's Jazz Pharmaceuticals position peaked at $1.75M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.